Medicare Enrolled
Dr. Paulette Dreher, DO
Urology Physician · Wyomissing, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dreher from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dreher?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dreher
Dr. Paulette Dreher is an urology physician in Wyomissing, PA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Dreher performed 2,257 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dreher received a total of $5,072 from 36 pharmaceutical and/or device companies across 112 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dreher is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ Top 28% volume in PA
$5,072 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,257
Medicare services
Top 28% in PA for urology physician
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
767 | $34 | $53 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
194 | $3 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $61 | $184 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
177 | $68 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
164 | $92 | $267 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
120 | $57 | $618 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $116 | $406 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
97 | $7 | $146 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
59 | $34 | $53 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
59 | $34 | $53 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
58 | $34 | $53 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
43 | $19 | $265 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $24 | $454 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
32 | $61 | $132 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
28 | $402 | $3,000 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $83 | $265 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
23 | $103 | $1,409 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $342 | $1,956 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $133 | $295 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $107 | $793 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $89 | $737 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
13 | $22 | $340 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.7% high complexity
9.2% medium
88.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,072
Total received (2018-2024)
Avg $725/year across 7 years
Top 28% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
112
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$793
2023
$512
2022
$615
2021
$537
2020
$156
2019
$611
2018
$1,849
Payments by company (2024)
ABBVIE INC.
$135
PFIZER INC.
$87
180 Medical, Inc.
$82
BLUEWIND MEDICAL
$79
Teleflex LLC
$74
Sumitomo Pharma America, Inc.
$58
Tolmar, Inc.
$55
UROGEN PHARMA, INC.
$47
Novartis Pharmaceuticals Corporation
$42
ConvaTec Inc.
$42
Dendreon Pharmaceuticals LLC
$32
Tempus AI, Inc
$30
PROCEPT BioRobotics Corporation
$16
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 38.4% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation of the Americas
$824
Teleflex LLC
$504
Coloplast Corp
$502
Boston Scientific Corporation
$432
BOSTON SCIENTIFIC CORPORATION
$254
Blue Earth Diagnostics Limited
$245
Medtronic USA, Inc.
$227
Astellas Pharma US Inc
$205
Dendreon Pharmaceuticals LLC
$181
ABBVIE INC.
$158
Axonics, Inc.
$136
UroGen Pharma, Inc.
$120
Olympus America Inc.
$115
Medical Device Business Services, Inc.
$108
Myovant Sciences Inc.
$91
PFIZER INC.
$87
Janssen Biotech, Inc.
$85
180 Medical, Inc.
$82
Sumitomo Pharma America, Inc.
$79
BLUEWIND MEDICAL
$79
Novartis Pharmaceuticals Corporation
$67
Tolmar, Inc.
$55
PALETTE LIFE SCIENCES, INC.
$47
UROGEN PHARMA, INC.
$47
Progenics Pharmaceuticals, Inc.
$43
ConvaTec Inc.
$42
AbbVie Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$36
C. R. Bard, Inc. & Subsidiaries
$33
Tempus AI, Inc
$30
Foundation Medicine, Inc.
$27
Medtronic, Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$22
PROCEPT BioRobotics Corporation
$16
Endo Pharmaceuticals Inc.
$15
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
AMS · AQUABEAM SYSTEM · AXIS · Axonics · Axumin · BOTOX · ELIGARD · ERLEADA · FOUNDATIONONE · GEMTESA · GENERAL ONCOLOGY · GENTLECATH · GREENLIGHT · General - Kidney Stone Disease · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · Myrbetriq · Nubeqa · ORGOVYX · Olympus EMR & ESD Devices · PLUVICTO · PROVENGE · PYLARIFY · RESTORELLE · REVI · REZUM · SKYLITE · SUPRIS · ShockPulse - SE · UROLIFT · UroLift System · XIAFLEX · XTANDI · Xofigo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
27
County median income
$77,684
Nearest hospital to ZIP centroid (approximate)
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dreher is a clinical cardiology specialist, with above-average Medicare volume (top 28% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dreher experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Dreher performed 767 infectious disease dna/rna test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dreher receive payments from pharmaceutical companies?
Yes. Dr. Dreher received a total of $5,072 from 36 companies across 112 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dreher's costs compare to other urology physicians in Wyomissing?
Dr. Dreher's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dreher) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Wyomissing
Browse urology physicians in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology